| Net loss | -25.91M |
| Depreciation and amortization | |
| Amortization of deferred financing costs | 796K |
| Stock issued to pay expense | |
| Share-based compensation | 358K |
| Restricted cash | |
| Accounts receivable | |
| Inventory | 101K |
| Prepaid expenses | -19K |
| Deposits | -6K |
| Accounts payable and accrued liabilities | 10.18M |
| Asset retirement and environmental obligations | |
| Impairment expense | |
| Gain on sale of assets | |
| Other, net | -5K |
| Net cash used in operating activities | |
| Additions to unproved oil and gas properties in China | |
| Other oil and gas investment | |
| Additions to other properties | -53K |
| Sale of oil and gas properties | |
| Sales of other fixed assets | |
| Net cash used in investing activities | |
| Net proceeds from exchangeable note | 0 |
| Net proceeds from sale of common stock | |
| Net proceeds from exercise of options | |
| Net proceeds from exercise of warrants | |
| Deferred financing costs | |
| Net cash provided by financing activities | |
| Net (decrease) increase in cash and cash equivalents | -13.52M |
| Cash and cash equivalents--beginning of period | 17.57M |
| Cash and cash equivalents--end of period | 4.05M |
| Common stock issued to convert notes payable | |